(NASDAQ: APLT) Applied Therapeutics's forecast annual revenue growth rate of 102.19% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Applied Therapeutics's revenue in 2024 is $9,993,000.On average, 1 Wall Street analysts forecast APLT's revenue for 2024 to be $1,821,253,493, with the lowest APLT revenue forecast at $1,821,253,493, and the highest APLT revenue forecast at $1,821,253,493. On average, 1 Wall Street analysts forecast APLT's revenue for 2025 to be $7,687,383,931, with the lowest APLT revenue forecast at $7,687,383,931, and the highest APLT revenue forecast at $7,687,383,931.
In 2026, APLT is forecast to generate $8,746,252,241 in revenue, with the lowest revenue forecast at $8,746,252,241 and the highest revenue forecast at $8,746,252,241.